Cutaneous and Mucosal Melanomas of Uncommon Sites: Where Do We Stand Now?

Area of Science:

• Oncology
• Dermatology
• Genetics

Background:

• Melanomas at uncommon sites, such as palms, soles, nail apparatus, oral mucosa, genital area, and scalp, are rare and often occur in specific ethnic groups.
• The rarity of these melanomas limits patient participation in clinical trials, despite their unique genetic characteristics.
• These genetic differences have significant implications for the efficacy of novel oncologic therapies.

Purpose of the Study:

• To review the clinical features, somatic alterations, and therapeutic strategies for melanomas of uncommon sites.
• To highlight the importance of distinguishing this melanoma subgroup for appropriate surgical and medical management.
• To emphasize the need for novel therapeutic targets due to the absence of common mutations found in cutaneous melanomas.

Main Methods:

• Literature review focusing on clinical presentation, genetic mutations, and treatment outcomes.
• Classification of melanomas based on anatomical location (cutaneous and mucosal).
• Analysis of prognostic factors and diagnostic challenges.

Main Results:

• Melanomas of uncommon sites can have a worse prognosis than those in other locations.
• Prompt diagnosis significantly influences patient outcomes.
• These melanomas often lack the genetic mutations typically found in cutaneous melanomas, such as BRAF or NRAS.
• The genetic landscape differs between cutaneous and mucosal subtypes.

Conclusions:

• Dermatologists and oncologists must recognize and manage melanomas of uncommon sites as a distinct subgroup.
• Developing new therapeutic strategies targeting novel molecular pathways is essential for improving outcomes in patients with wild-type or non-responder melanomas.
• Further research into the unique genetic profiles of these rare melanomas is required to advance treatment options and alter the current prognosis.